Search

Your search keyword '"Buommino E"' showing total 172 results

Search Constraints

Start Over You searched for: Author "Buommino E" Remove constraint Author: "Buommino E"
172 results on '"Buommino E"'

Search Results

51. Plant Derived Natural Products against Pseudomonas aeruginosa and Staphylococcus aureus: Antibiofilm Activity and Molecular Mechanisms

52. Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-Methylfunicone from Penicillium pinophilum and cisplatin

53. Untargeted metabolomics profiling of Morus alba twigs extract and antibacterial activity of pure metabolites.

54. A First-in-Class Pyrazole-isoxazole Enhanced Antifungal Activity of Voriconazole: Synergy Studies in an Azole-Resistant Candida albicans Strain, Computational Investigation and in Vivo Validation in a Galleria mellonella Fungal Infection Model.

55. The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases.

56. Unveiling the modulation of Pseudomonas aeruginosa virulence and biofilm formation by selective histone deacetylase 6 inhibitors.

57. Synthesis and antimicrobial properties of guanidine-functionalized labdane type diterpenoids.

58. Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans .

59. Hands-on synthesis of furanamides and evaluation of their antimicrobial activity.

60. Zooming into Gut Dysbiosis in Parkinson's Disease: New Insights from Functional Mapping.

61. Rejuvenating the [1, 2, 3]-triazolo [1,5-a]quinoxalin-4(5 H )-one scaffold: Synthesis and derivatization in a sustainable guise and preliminary antimicrobial evaluation.

62. Phytochemical Investigation of Myrcianthes cisplatensis : Structural Characterization of New p -Coumaroyl Alkylphloroglucinols and Antimicrobial Evaluation against Staphylococcus aureus .

63. Gallomyrtucommulones G and H, New Phloroglucinol Glycosides, from Bioactive Fractions of Myrtus communis against Staphylococcus Species.

64. Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities.

65. Coupling Interrupted Fischer and Multicomponent Joullié-Ugi to Chase Chemical Diversity: from Batch to Sustainable Flow Synthesis of Peptidomimetics.

66. Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates.

67. Synergism of a Novel 1,2,4-oxadiazole-containing Derivative with Oxacillin against Methicillin-Resistant Staphylococcus aureus .

68. First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment.

69. First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat.

70. Synergistic Effect of Abietic Acid with Oxacillin against Methicillin-Resistant Staphylococcus pseudintermedius .

71. Novel temporin L antimicrobial peptides: promoting self-assembling by lipidic tags to tackle superbugs.

72. Plant Derived Natural Products against Pseudomonas aeruginosa and Staphylococcus aureus : Antibiofilm Activity and Molecular Mechanisms.

73. Synthesis of novel lignan-like compounds and their antimicrobial activity.

74. Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection.

75. Synthesis of 3-benzoyl-4-benzylfurans structural related to furolignans.

76. The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L.

78. Antimicrobial and anti-biofilm properties of novel synthetic lignan-like compounds.

79. Gut Microbiota Features in Young Children With Autism Spectrum Disorders.

80. Effect of 1064-nm Q-switched Nd:YAG laser on invasiveness and innate immune response in keratinocytes infected with Candida albicans.

82. Evaluation of the antioxidant properties of carexanes in AGS cells transfected with the Helicobacter pylori's protein HspB.

83. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains.

84. Phytochemical study of Helichrysum italicum (Roth) G. Don: Spectroscopic elucidation of unusual amino-phlorogucinols and antimicrobial assessment of secondary metabolites from medium-polar extract.

85. Correlation between genetic variability and virulence factors in clinical strains of Malassezia pachydermatis of animal origin.

86. β-Defensins: Work in Progress.

87. Lactobacillus crispatus mediates anti-inflammatory cytokine interleukin-10 induction in response to Chlamydia trachomatis infection in vitro.

88. In vitro growth versus inhibition of growth of Malassezia pachydermatis in the presence of the antibacterial drug gentamicin.

89. Transforming activities of Chlamydia pneumoniae in human mesothelial cells.

90. Alterations of skin innate immunity in lymphedematous limbs: Correlations with opportunistic diseases.

91. AlphaVBeta5 integrins mediates Pseudomonas fluorescens interaction with A549 cells

92. Recent advances in natural product-based anti-biofilm approaches to control infections.

93. Simvastatin reduces melanoma progression in a murine model.

94. Spectroscopic identification and anti-biofilm properties of polar metabolites from the medicinal plant Helichrysum italicum against Pseudomonas aeruginosa.

95. Innate immune response in human keratinocytes infected by a feline isolate of Malassezia pachydermatis.

96. The Helicobacter pylori protein HspB interferes with Nrf2/Keap1 pathway altering the antioxidant response of Ags cells.

97. Patented natural avocado sugar modulates the HBD-2 and HBD-3 expression in human keratinocytes through toll-like receptor-2 and ERK/MAPK activation.

98. Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-methylfunicone from Penicillium pinophilum and cisplatin.

99. Patenting Penicillium strains.

100. Structure and function of the epidermis related to barrier properties.

Catalog

Books, media, physical & digital resources